Vol. 40 | Vol. 40(1) - January / February 2022 | COLUMN: Quality & Supply Chain Security

What will Quality Management look like in 2025?

by 16 February 2022

J. Kelleher 16 February 2022

artificial intelligence

content management

life sciences

pharma

quality & supply chain security

Quality Management

smart automation

JAMES KELLEHER
Generis Enterprise Technology Limited, London, United Kingdom

What does the future hold for Quality Management as smart automation offers new ways to monitor and pre-emptively intervene in pharmaceutical production? Late last year, a panel of experts from Merck, Syneos Health and Accenture, chaired by James Kelleher, CEO of Generis, debated the subject.

ABOUT THE AUTHOR

James Kelleher, CEO of Generis, helps life science companies to decrease their time to market by providing a comprehensive platform for the core processes, data, and content of the product development lifecycle. Spanning applications across Regulatory, Quality, Safety, Clinical, and other enterprise-wide processes, Generis works with customers such as Bayer, Merck KGaA, Pfizer, BMS, Gilead, AstraZeneca and Otsuka

Cell and gene therapies: Technology and opportunities

Latest issue

Vol. 44(4) – July / August 2026

View Issue

Content from magazine

“Contents from Magazine” offers curated articles and insights from the field of chemistry, focused on research, data, and scientific developments

View all content

What will Quality Management look like in 2025?

You may also like

Targets and challenges of Pharma Supply Chain Manufacturers

Indena’s CDMO services are more and more strategic

Cell and gene therapies: Technology and opportunities

Angelini Pharma continues its commitment to HPAPI services

NEWS

Olon – Highly potent products for a more sustainable drug supply...

European APIs producers: key role in the future scenario of health sys...

GRIFOLS – Sharing a few words about small-volume parenteral manu...